Editas Medicine
EDIT
£0.92
Share price
5.75%
Change (1 day)
-84.09%
Change (1 year)
P/S ratio for Editas Medicine (EDIT)
P/S ratio as of April 2025 (TTM): 2.90
According to Editas Medicine 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.6983. At the end of 2024 the company had a P/S ratio of 3.09.
P/S ratio history for Editas Medicine from 2016 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 3.09 | -70.81% |
| 2023 | 10.6 | -65.78% |
| 2022 | 30.9 | -56.47% |
| 2021 | 71.1 | 47.6% |
| 2020 | 48.2 | -38.56% |
| 2019 | 78.4 | 125.7% |
| 2018 | 34.7 | -63.16% |
| 2017 | 94.3 | -4.07% |
| 2016 | 98.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 3.18 | 9.65% | Jersey |
 | 1.41 | -51.25% | 🇺🇸 USA |
 | 32.9 | 1,033.87% | 🇺🇸 USA |
 | 17.4 | 499.82% | 🇬🇧 UK |